Cold & Cough Remedies - Moldova

  • Moldova
  • In Moldova, the revenue in the Cold & Cough Remedies market market reached US$20.40m in 2024.
  • It is projected to experience an annual growth rate of 5.26% (CAGR 2024-2029).
  • When compared globally, the highest revenue is generated the in the United States, amounting to US$11,190.00m in 2024.
  • Looking at the per person revenues in Moldova, it amounts to US$6.13 in 2024.
  • Despite its small market size, Moldova has a growing demand for cold and cough remedies, driven by a high prevalence of respiratory infections and a growing awareness of self-medication.

Key regions: United States, Japan, Australia, United Kingdom, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Cold & Cough Remedies market in Moldova has been experiencing steady growth in recent years.

Customer preferences:
In Moldova, like in many other countries, customers prefer over-the-counter remedies for cold and cough. They are more inclined towards self-medication and prefer to purchase these remedies without a prescription. This preference is driven by convenience and the belief that over-the-counter remedies are effective in treating common cold and cough symptoms. Customers also value affordability and are more likely to choose generic brands over expensive branded products.

Trends in the market:
One of the key trends in the Cold & Cough Remedies market in Moldova is the increasing demand for natural and herbal remedies. Customers are becoming more conscious about the ingredients used in the remedies they consume and are opting for products that are perceived to be more natural and less harmful. This trend is in line with the global shift towards natural and organic products in the healthcare industry.Another trend in the market is the growing popularity of combination remedies. Customers are looking for products that can address multiple symptoms at once, such as a remedy that can relieve both cold and cough symptoms. Combination remedies provide convenience and cost-effectiveness, as customers do not have to purchase multiple products.

Local special circumstances:
Moldova has a relatively high prevalence of cold and cough due to its cold winters and changing weather patterns. This creates a constant demand for remedies to alleviate symptoms and provide relief. Additionally, the country has a growing population, which further contributes to the demand for cold and cough remedies.

Underlying macroeconomic factors:
The Cold & Cough Remedies market in Moldova is influenced by several macroeconomic factors. One of the key factors is the overall economic development of the country. As the economy grows and people's disposable incomes increase, they are more likely to spend on healthcare products, including cold and cough remedies.Another factor is the level of healthcare infrastructure and access to healthcare services. Moldova has been making efforts to improve its healthcare system, which includes increasing access to healthcare services and promoting self-medication. These initiatives have contributed to the growth of the Cold & Cough Remedies market.In conclusion, the Cold & Cough Remedies market in Moldova is developing due to customer preferences for over-the-counter remedies, the increasing demand for natural and herbal products, and the growing popularity of combination remedies. The local special circumstances, such as the prevalence of cold and cough and the country's growing population, further contribute to the market's growth. The underlying macroeconomic factors, including economic development and improved healthcare infrastructure, also play a significant role in the market's development.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)